v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common stock – Class A
Preferred Stock
Preferred stock – Series A
Common stock
Common stock – Class A
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023     0      
Beginning balance at Dec. 31, 2023 $ 3,187   $ 0 $ 0 $ 376,234 $ (373,047)
Beginning balance (in shares) at Dec. 31, 2023       591,712    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon vesting of RSUs (in shares)       2,613    
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)       (425)    
Share repurchase related to Section 16 Officer tax coverage exchange (3)       (3)  
Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares)       158,572    
Issuance of common stock and related warrants in registered offering, net of issuance costs 7,171       7,171  
Issuance of common stock upon exercise of pre-funded warrants (in shares)       435,092    
Stock-based compensation - stock options, RSAs, RSUs 1,443       1,443  
Net loss (8,313)         (8,313)
Ending balance (in shares) at Mar. 31, 2024     0      
Ending balance at Mar. 31, 2024 3,485   $ 0 $ 0 384,845 (381,360)
Ending balance (in shares) at Mar. 31, 2024       1,187,564    
Beginning balance (in shares) at Dec. 31, 2023     0      
Beginning balance at Dec. 31, 2023 3,187   $ 0 $ 0 376,234 (373,047)
Beginning balance (in shares) at Dec. 31, 2023       591,712    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (15,329)          
Ending balance (in shares) at Jun. 30, 2024     0      
Ending balance at Jun. 30, 2024 (1,796)   $ 0 $ 0 386,580 (388,376)
Ending balance (in shares) at Jun. 30, 2024       1,187,564    
Beginning balance (in shares) at Mar. 31, 2024     0      
Beginning balance at Mar. 31, 2024 3,485   $ 0 $ 0 384,845 (381,360)
Beginning balance (in shares) at Mar. 31, 2024       1,187,564    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation - stock options, RSAs, RSUs 1,735       1,735  
Net loss (7,016)         (7,016)
Ending balance (in shares) at Jun. 30, 2024     0      
Ending balance at Jun. 30, 2024 $ (1,796)   $ 0 $ 0 386,580 (388,376)
Ending balance (in shares) at Jun. 30, 2024       1,187,564    
Beginning balance (in shares) at Dec. 31, 2024 0   0      
Beginning balance at Dec. 31, 2024 $ (7,810)   $ 0 $ 0 400,183 (407,993)
Beginning balance (in shares) at Dec. 31, 2024   2,780,597   2,780,597    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options 0          
Issuance of common stock upon vesting of RSUs (in shares)       1,951    
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)       (424)    
Share repurchase related to Section 16 Officer tax coverage exchange (1)       (1)  
Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares)       300,000    
Issuance of common stock and related warrants in registered offering, net of issuance costs 4,401       4,401  
Issuance of common stock upon exercise of pre-funded warrants (in shares)       1,176,886    
Issuance of common stock in connection with prior warrant inducement, net of issuance costs (in shares)       331,000    
Issuance of common stock in connection with warrant inducement, net of issuance costs 1,889       1,889  
Issuance of common stock for convertible note principal and interest (in shares)       190,000    
Issuance of common stock for convertible note principal and interest 664       664  
Stock-based compensation - stock options, RSAs, RSUs 1,057       1,057  
Net loss (6,172)         (6,172)
Ending balance (in shares) at Mar. 31, 2025     0      
Ending balance at Mar. 31, 2025 $ (5,972)   $ 0 $ 0 408,193 (414,165)
Ending balance (in shares) at Mar. 31, 2025       4,780,010    
Beginning balance (in shares) at Dec. 31, 2024 0   0      
Beginning balance at Dec. 31, 2024 $ (7,810)   $ 0 $ 0 400,183 (407,993)
Beginning balance (in shares) at Dec. 31, 2024   2,780,597   2,780,597    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (12,622)          
Ending balance (in shares) at Jun. 30, 2025 0   0      
Ending balance at Jun. 30, 2025 $ (9,971)   $ 0 $ 0 410,644 (420,615)
Ending balance (in shares) at Jun. 30, 2025   5,824,498   5,824,498    
Beginning balance (in shares) at Mar. 31, 2025     0      
Beginning balance at Mar. 31, 2025 (5,972)   $ 0 $ 0 408,193 (414,165)
Beginning balance (in shares) at Mar. 31, 2025       4,780,010    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon vesting of RSUs (in shares)       159    
Share repurchase related to Section 16 Officer tax coverage exchange (in shares)       (15)    
Issuance of common stock in connection with prior warrant inducement, net of issuance costs (in shares)       740,429    
Issuance of common stock in connection with warrant inducement, net of issuance costs (25)       (25)  
Issuance of common stock for convertible note principal and interest (in shares)       112,576    
Issuance of common stock for convertible note principal and interest 199       199  
Issuance of common stock in settlement of accounts payable and customer deposits (in shares)       191,339    
Issuance of common stock in settlement of accounts payable and customer deposits 338       338  
Deferred financing costs for warrant modification 400       400  
Issuance of warrants with convertible debt 572       572  
Stock-based compensation - stock options, RSAs, RSUs 967       967  
Net loss $ (6,450)         (6,450)
Ending balance (in shares) at Jun. 30, 2025 0   0      
Ending balance at Jun. 30, 2025 $ (9,971)   $ 0 $ 0 $ 410,644 $ (420,615)
Ending balance (in shares) at Jun. 30, 2025   5,824,498   5,824,498